➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: August 11, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Tobramycin Sulfate patents expire, and what generic alternatives are available?

Tobramycin Sulfate is a drug marketed by Akorn, Apothecon, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Mylan Labs Ltd, Teva Pharms Usa, Watson Labs Inc, West-ward Pharms Int, Xellia Pharms Aps, and Xgen Pharms. and is included in twenty-seven NDAs.

The generic ingredient in TOBRAMYCIN SULFATE is tobramycin sulfate. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Tobramycin Sulfate

A generic version of TOBRAMYCIN SULFATE was approved as tobramycin sulfate by WEST-WARD PHARMS INT on April 26th, 1991.

  Start Trial

Drug patent expirations by year for TOBRAMYCIN SULFATE
Recent Clinical Trials for TOBRAMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

McMaster UniversityPhase 4
University of Lausanne HospitalsN/A

See all TOBRAMYCIN SULFATE clinical trials


US Patents and Regulatory Information for TOBRAMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER tobramycin sulfate INJECTABLE;INJECTION 063081-001 Jul 31, 1990 RX No Yes   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa TOBRAMYCIN SULFATE (PHARMACY BULK) tobramycin sulfate INJECTABLE;INJECTION 065120-001 Nov 29, 2002 RX No Yes   Start Trial   Start Trial   Start Trial
Hospira TOBRAMYCIN SULFATE (PHARMACY BULK) tobramycin sulfate INJECTABLE;INJECTION 063116-001 May 18, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.